SCHEMBL14597986

SCHEMBL14597986

CC1CCCCC1c1cc(Cl)n2ccc(Br)c2n1

nearest known ligand 0.33

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
▸ PDE10A Q9Y233 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12953405 0.77 CDK2 (0.40) —
SCHEMBL13304699 0.69 KDM4E (0.31) —
SCHEMBL13146264 0.62 CDK2 (0.37) —
SCHEMBL12952968 0.59 CDK9 (0.37) PDE10A
SCHEMBL21573355 0.59 TAS1R3 (0.36) —
SCHEMBL12953240 0.57 GSK3B (0.55) —
SCHEMBL14560679 0.56 ADORA1 (0.36) —
SCHEMBL21078310 0.56 PSMB5 (0.36) —
SCHEMBL8130407 0.56 MDM2 (0.45) —
SCHEMBL13983010 0.56 SLC6A3 (0.47) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7161003-B1 Pyrazolopyrimidines as cyclin dependent kinase inhibitors SCHERING CORPORATION (US) 2007-01-09 — — US disclosed
US-7161003-B1 Pyrazolopyrimidines as cyclin dependent kinase inhibitors SCHERING CORPORATION (US) 2007-01-09 — — US disclosed
Send feedback